Carregant...

Evaluation of in vitro antileishmanial efficacy of cyclosporin A and its non-immunosuppressive derivative, dihydrocyclosporin A

BACKGROUND: New therapeutic drugs are urgently needed against visceral leishmaniasis because current drugs, such as pentavalent antimonials and miltefosine, produce severe side effects and development of resistance. Whether cyclosporine A (CsA) and its derivatives can be used as therapeutic drugs fo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Parasit Vectors
Autors principals: Zheng, Zhi-Wan, Li, Jiao, Chen, Han, He, Jin-Lei, Chen, Qi-Wei, Zhang, Jian-Hui, Zhou, Qi, Chen, Da-Li, Chen, Jian-Ping
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7035640/
https://ncbi.nlm.nih.gov/pubmed/32085719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13071-020-3958-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!